SCHEMBL356412

SCHEMBL356412

[CH2]c1ccc(OCC)c(OC)c1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.59
GAA P10253 2/20 0.59
MAPT P10636 2/20 0.59
TSHR P16473 1/20 0.54
MAPK1 P28482 2/20 0.53
CALM1 P0DP23 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.47
PDE4A P27815 3/20 0.46
PDE4B Q07343 3/20 0.46
PDE4C Q08493 3/20 0.46
PDE4D Q08499 3/20 0.46
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 1/20 0.46
ALOX12 P18054 1/20 0.46
KMT2A Q03164 1/20 0.46
HPGD P15428 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
AMY1A P0DUB6 1/20 0.44
IGF1R P08069 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1379795 0.92 PDE4A (0.54) KDM4EGAAMAPTTSHRMAPK1
SCHEMBL309719 0.90 KDM4E (0.46) KDM4EGAAMAPTTSHRMAPK1
SCHEMBL9117605 0.83 PRKCE (0.46) KDM4EMAPTMAPK1ALDH1A1MEN1
SCHEMBL27090 0.83 CA2 (0.54) KDM4EGAATSHRMAPK1PDE4A
SCHEMBL1066757 0.82 THRA (0.49) ALDH1A1MEN1KMT2A
SCHEMBL9116570 0.80 THRA (0.51) ALDH1A1
SCHEMBL4436990 0.79 ALDH1A1 (0.50) KDM4EGAAMAPTTSHRSMN1; SMN2
SCHEMBL20985816 0.78 MAOB (0.49) KDM4EGAAMAPTTSHRPDE4B
SCHEMBL16961146 0.78 S1PR1 (0.39) KDM4EGAAMAPTTSHRMAPK1
SCHEMBL3055313 0.78 ALDH1A1 (0.43) KDM4EGAAMAPTTSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118234628-A Thermosensitive recording medium 日本制纸株式会社 2024-06-21 CN disclosed
US-20240190156-A1 THERMOSENSITIVE RECORDING MEDIUM NIPPON PAPER INDUSTRIES CO., LTD. (JP) 2024-06-13 US disclosed
US-20240190816-A1 N,N'-DIARYLUREA DERIVATIVE, MANUFACTURING METHOD THEREOF, AND THERMOSENSITIVE RECORDING MATERIAL USING SAME SANKO CO., LTD. (JP) 2024-06-13 US disclosed
US-20240181797-A1 THERMOSENSITIVE RECORDING LAYER FORMING LIQUID, THERMOSENSITIVE RECORDING MEDIUM AND PRODUCTION METHOD THEREOF, AND IMAGE RECORDING METHOD RICOH COMPANY, LTD. (JP) 2024-06-06 US disclosed
US-11945769-B2 N,N′-diarylurea derivative, manufacturing method thereof, and thermosensitive recording material using same SANKO CO., LTD. (JP) 2024-04-02 US disclosed
US-11912052-B2 Thermosensitive recording medium NIPPON PAPER INDUSTRIES CO., LTD. 2024-02-27 US disclosed
EP-4316861-A1 HEAT-SENSITIVE RECORDING MATERIAL Nippon Paper Industries Co., Ltd. (JP) 2024-02-07 EP disclosed
EP-4313612-A1 THERMOSENSITIVE RECORDING LAYER FORMING LIQUID, THERMOSENSITIVE RECORDING MEDIUM AND PRODUCTION METHOD THEREOF, AND IMAGE RECORDING METHOD Ricoh Company, Ltd. (JP) 2024-02-07 EP disclosed
EP-4309907-A1 HEAT-SENSITIVE RECORDING MATERIAL Nippon Paper Industries Co., Ltd. (JP) 2024-01-24 EP disclosed
CN-117098670-A Thermosensitive recording medium 日本制纸株式会社 2023-11-21 CN disclosed
US-5155113-A Administering 5-fluorouracil and derivatives with pyridine and pyridone derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-10-13 US disclosed
EP-0180188-B1 A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-04-15 EP disclosed
EP-0436902-A1 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-07-17 EP disclosed
US-4983609-A Anticancer agents OTSUKA PHARMACEUTICAL (JP) 1991-01-08 US disclosed
US-4864021-A ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-09-05 US disclosed
EP-0323441-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-07-05 EP disclosed
EP-0180897-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-14 EP disclosed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 EP disclosed
US-4497815-A 1-(N-Substituted carbamoyl)-5-fluorouracil derivatives and the carcinostatic agents containing same as active ingredients Ozaki, Shoichiro (JP) 1985-02-05 US disclosed
US-3936462-A CNS DEPRESSANT, ANALGESIC STERLING DRUG INC. (US) 1976-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11945769-B2 N,N′-diarylurea derivative, manufacturing method thereof, and thermosensitive recording material using same SCN1A, SCN1B, NAAA KDM4E 2891/4885GAA 3045/4885MAPT 3553/4885
US-20240190816-A1 N,N'-DIARYLUREA DERIVATIVE, MANUFACTURING METHOD THEREOF, AND THERMOSENSITIVE RECORDING MATERIAL USING SAME SCN1A, SCN1B, SCN2A KDM4E 2343/4885GAA 2519/4885MAPT 3377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.